Clinical Trial Update: Efficacy and Safety of Timolol for TKI Induced Paronychia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating timolol for treatment of paronychia induced by TKIs, with efficacy and safety data yet to be reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paronychia

Drugs mentioned

• Timolol (timolol)

Snippet

Sponsor: Queen Mary Hospital, Hong Kong | Conditions: Paronychia | Phase 3 | Status: UNKNOWN